Literature DB >> 3806337

Complement and 5-HT increase phosphatidylcholine incorporation into the outer bilayers of Schistosoma mansoni.

B W Young, R B Podesta.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 3806337

Source DB:  PubMed          Journal:  J Parasitol        ISSN： 0022-3395            Impact factor:   1.276


× No keyword cloud information.
  10 in total

1.  Role of antibodies in Sm-p80-mediated protection against Schistosoma mansoni challenge infection in murine and nonhuman primate models.

Authors:  Workineh Torben; Gul Ahmad; Weidong Zhang; Afzal A Siddiqui
Journal:  Vaccine       Date:  2011-01-28       Impact factor: 3.641

2.  Simultaneous priming with DNA encoding Sm-p80 and boosting with Sm-p80 protein confers protection against challenge infection with Schistosoma mansoni in mice.

Authors:  Loc Le; Weidong Zhang; Souvik Karmakar; Gul Ahmad; Workineh Torben; Afzal A Siddiqui
Journal:  Parasitol Res       Date:  2014-01-23       Impact factor: 2.289

3.  Cross-species protection: Schistosoma mansoni Sm-p80 vaccine confers protection against Schistosoma haematobium in hamsters and baboons.

Authors:  Souvik Karmakar; Weidong Zhang; Gul Ahmad; Workineh Torben; Mayeen U Alam; Loc Le; Raymond T Damian; Roman F Wolf; Gary L White; David W Carey; Darrick Carter; Steven G Reed; Afzal A Siddiqui
Journal:  Vaccine       Date:  2014-01-04       Impact factor: 3.641

4.  Sm-p80-based DNA vaccine provides baboons with levels of protection against Schistosoma mansoni infection comparable to those achieved by the irradiated cercarial vaccine.

Authors:  Weidong Zhang; Gul Ahmad; Workineh Torben; Zahid Noor; Loc Le; Raymond T Damian; Roman F Wolf; Gary L White; Maria Chavez-Suarez; Ronald B Podesta; Ronald C Kennedy; Afzal A Siddiqui
Journal:  J Infect Dis       Date:  2010-04-01       Impact factor: 5.226

5.  Protective effects of Sm-p80 in the presence of resiquimod as an adjuvant against challenge infection with Schistosoma mansoni in mice.

Authors:  Gul Ahmad; Weidong Zhang; Workineh Torben; Zahid Noor; Afzal A Siddiqui
Journal:  Int J Infect Dis       Date:  2010-07-13       Impact factor: 3.623

6.  Sm-p80-based DNA vaccine formulation induces potent protective immunity against Schistosoma mansoni.

Authors:  G Ahmad; W Torben; W Zhang; M Wyatt; A A Siddiqui
Journal:  Parasite Immunol       Date:  2009-03       Impact factor: 2.280

7.  Protective and antifecundity effects of Sm-p80-based DNA vaccine formulation against Schistosoma mansoni in a nonhuman primate model.

Authors:  Gul Ahmad; Weidong Zhang; Workineh Torben; Raymond T Damian; Roman F Wolf; Gary L White; Maria Chavez-Suarez; Ronald C Kennedy; Afzal A Siddiqui
Journal:  Vaccine       Date:  2009-03-10       Impact factor: 3.641

8.  Prime-boost and recombinant protein vaccination strategies using Sm-p80 protects against Schistosoma mansoni infection in the mouse model to levels previously attainable only by the irradiated cercarial vaccine.

Authors:  Gul Ahmad; Weidong Zhang; Workineh Torben; Chad Haskins; Sue Diggs; Zahid Noor; Loc Le; Afzal A Siddiqui
Journal:  Parasitol Res       Date:  2009-10-07       Impact factor: 2.289

Review 9.  Experimental vaccines in animal models for schistosomiasis.

Authors:  Afzal A Siddiqui; Gul Ahmad; Raymond T Damian; Ronald C Kennedy
Journal:  Parasitol Res       Date:  2008-02-08       Impact factor: 2.289

10.  Schistosoma mansoni antigen Sm-p80: prophylactic efficacy using TLR4 agonist vaccine adjuvant glucopyranosyl lipid A-Alum in murine and non-human primate models.

Authors:  Weidong Zhang; Gul Ahmad; Adebayo J Molehin; Workineh Torben; Loc Le; Eunjee Kim; Samra Lazarus; Arif J Siddiqui; Darrick Carter; Afzal A Siddiqui
Journal:  J Investig Med       Date:  2018-07-10       Impact factor: 2.895
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.